Johnson, C.R.; Kangas, B.D.; Jutkiewicz, E.M.; Bergman, J.; Coop, A.
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders. Biomedicines 2022, 10, 398.
https://doi.org/10.3390/biomedicines10020398
AMA Style
Johnson CR, Kangas BD, Jutkiewicz EM, Bergman J, Coop A.
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders. Biomedicines. 2022; 10(2):398.
https://doi.org/10.3390/biomedicines10020398
Chicago/Turabian Style
Johnson, Chad R., Brian D. Kangas, Emily M. Jutkiewicz, Jack Bergman, and Andrew Coop.
2022. "Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders" Biomedicines 10, no. 2: 398.
https://doi.org/10.3390/biomedicines10020398
APA Style
Johnson, C. R., Kangas, B. D., Jutkiewicz, E. M., Bergman, J., & Coop, A.
(2022). Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders. Biomedicines, 10(2), 398.
https://doi.org/10.3390/biomedicines10020398